首页> 外文OA文献 >PRP10: PREDICTING THE BENEFIT OF OPTIMIZING SEVERE ASTHMA MANAGEMENT IN A MANAGED CARE SETTING:A COST-BENEFIT ANALYSIS COMPARING THE COMBINATION OF FLUTICASONE PROPIONATE AND SALMETEROL (FPS) AND ZAFIRLUKAST

【2h】

PRP10: PREDICTING THE BENEFIT OF OPTIMIZING SEVERE ASTHMA MANAGEMENT IN A MANAGED CARE SETTING:A COST-BENEFIT ANALYSIS COMPARING THE COMBINATION OF FLUTICASONE PROPIONATE AND SALMETEROL (FPS) AND ZAFIRLUKAST

机译：PRP10：在管理的照护环境中预测优化重度哮喘的益处：丙酸氟替卡松与沙美特罗（FPS）和ZAFIRLUKAST结合使用的成本效益分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Joglekar A; Chao C; Kadison P;
展开▼
作者单位

展开▼
年度 2003
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The efficacy and safety of fluticasone propionate/formoterol compared with fluticasone propionate/salmeterol in treating pediatric asthma: a systematic review and meta-analysis [J] . Renzheng Guan, Yanli Liu, Dunqiang Ren, Journal of International Medical Research . 2020,第3期

机译：氟基丙酸酯/蛋白质与氟替卡松丙酸盐/萨尔梅托治疗儿科哮喘的疗效和安全性：系统综述和荟萃分析
2. Efficacy and safety of fluticasone furoate/vilanterol compared with fluticasone propionate/salmeterol combination in adult and adolescent patients with persistent asthma: A randomized trial [J] . WoodcockA., BleeckerE.R., L?tvallJ., Chest: The Journal of Circulation, Respiration and Related Systems . 2013,第4期

机译：氟替卡松糠酸酯/维兰特罗与丙酸氟替卡松/沙美特罗联合治疗在患有持续性哮喘的成人和青少年患者中的疗效和安全性：一项随机试验
3. Efficacy and Safety of Fluticasone Furoate/Vilanterol Compared With Fluticasone Propionate/Salmeterol Combination in Adult and Adolescent Patients With Persistent Asthma: A Randomized Trial [J] . Anna Ellsworth, Ashley Woodcock, Eric D. Bateman, Chest . 2013,第4期

机译：氟替卡松富尿酸/紫杉醇与丙酸氟替卡松/沙美特罗联合治疗成人和青少年持续性哮喘的疗效和安全性：一项随机试验
4. A comprehensive costing analysis of intensive case management for individuals with severe mental illness and a history of homelessness, including cost-effectiveness as compared to standard care. [D] . Birnie, Sarah. 2009

机译：对严重精神疾病和无家可归史的患者进行强化病例管理的综合成本分析，包括与标准护理相比的成本效益。
5. Efficacy and Safety of Fluticasone Furoate/Vilanterol Compared With Fluticasone Propionate/Salmeterol Combination in Adult and Adolescent Patients With Persistent Asthma [O] . Ashley Woodcock, Eugene R. Bleecker, Jan Lötvall, -1

机译：氟替卡松富尿酸/紫杉醇与丙酸氟替卡松/沙美特罗联合治疗成人和青少年持续性哮喘的疗效和安全性
6. Efficacy and Tolerability of Fluticasone Propionate /Salmeterol MDI Compared With Concurrent Fluticasone Propionate and Salmeterol MDI in Adult Patients with Persistent Asthma: A Randomized, Double-Blind 12-Week Study [O] . Rebello CJ 2017

机译：丙酮丙酸盐/萨米特洛MDI的疗效和耐受性与成年哮喘患者同时氟酮丙酸盐和萨尔梅托MDI相比：随机，双盲12周研究

PRP10: PREDICTING THE BENEFIT OF OPTIMIZING SEVERE ASTHMA MANAGEMENT IN A MANAGED CARE SETTING:A COST-BENEFIT ANALYSIS COMPARING THE COMBINATION OF FLUTICASONE PROPIONATE AND SALMETEROL (FPS) AND ZAFIRLUKAST

著录项

引文网络

相似文献

相关主题

期刊订阅